The North America veterinary clinical trials market size was valued at USD 1,629.11 million in 2023 and is expected to grow at USD 3,841.20 million in 2032.
The North America veterinary clinical trials market is projected to grow at a CAGR of 10.0% during the forecast period.
The U.S. veterinary clinical trials market accounted for the largest market share in 2023.
The key players in the North America veterinary clinical trials market are Argenta, Bioagile Therapeutics Pvt. Ltd., Boehringer Ingelheim International GmbH., Charles River Laboratory, Clinvet, IDEXX Laboratories, Inc., Labcorp Drug Development, Merck & Co., Inc., Ondax Scientific, and Vivesto AB.
In 2023, the companion animal segment accounted for the largest market share.
The pharmaceutical and biopharmaceutical companies segment accounted for the largest market share in 2023.